Biotoxtech Co. Ltd (086040) — Capital Reinvestment Ratio
Biotoxtech Co. Ltd (086040) has a Capital Reinvestment Ratio of 0.13x as of June 2025, meaning it reinvests 0% of its operating cash flow (₩649.06 Million) in capital expenditures (₩84.65 Million). See 086040 net asset quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Biotoxtech Co. Ltd Capital Reinvestment Ratio (2011–2021)
This chart tracks Biotoxtech Co. Ltd's Capital Reinvestment Ratio across 8 annual periods. Check 086040 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Biotoxtech Co. Ltd (2011–2021)
Year-by-year Capital Reinvestment Ratio for Biotoxtech Co. Ltd from 2011 to 2021. For live market cap and broader valuation context, see market value of Biotoxtech Co. Ltd.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2021 | 1.75x | ₩4.35 Billion | ₩7.62 Billion | ▲ +485.5% |
| 2020 | 0.30x | ₩4.56 Billion | ₩1.37 Billion | ▼ -3.8% |
| 2019 | 0.31x | ₩1.44 Billion | ₩449.34 Million | ▼ -58.9% |
| 2018 | 0.76x | ₩3.06 Billion | ₩2.32 Billion | ▲ +33.8% |
| 2017 | 0.57x | ₩6.02 Billion | ₩3.41 Billion | ▲ +508.3% |
| 2016 | 0.09x | ₩5.28 Billion | ₩491.52 Million | ▼ -91.8% |
| 2012 | 1.13x | ₩1.63 Billion | ₩1.85 Billion | ▲ +25.5% |
| 2011 | 0.90x | ₩3.28 Billion | ₩2.96 Billion | — |